Sona Nanotech Inc.
Purdy’s Wharf Tower II
Suite 2001 1969 Upper Water Street
Halifax, NS B3J 3R7
Canada
902 442 0653
https://www.sonanano.com
版塊: Healthcare
行業: Diagnostics & Research
全職員工:
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Mr. David Andrew Regan | Chief Executive Officer | 260k | 無 | 1969 |
| Mr. Robert William George Randall CPA | CFO & Corporate Secretary | 63.11k | 無 | 1963 |
| Dr. Len Pagliaro Ph.D. | CSO & Director | 218.64k | 無 | 無 |
| Dr. Kulbir Singh Ph.D. | Co-Founder & Head of R&D | 無 | 無 | 無 |
| Dr. Mike McAlduff | Director of R&D & Production and Founder | 無 | 無 | 無 |
| Dr. Gerrard Marangoni | Co-Founder & Member of Scientific Advisory Board | 無 | 無 | 無 |
| Mr. Darren Rowles | Head of Diagnostics | 189k | 無 | 1979 |
截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 CAD。
描述
Sona Nanotech Inc. operates as a nanotechnology life sciences company. It develops targeted hyperthermia therapy for cancer treatment; and nanomedical therapy for the treatment of colorectal cancer. The company also develops gold nanoparticle products; lateral flow assay rapid tests; bovine TB tests; and concussion screening tests. Sona Nanotech Inc. was founded in 2013 and is based in Halifax, Canada.
公司管治
截至 無 止，Sona Nanotech Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。
企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。
